Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
American Renal Associates Holdings, Inc. (ARA)
|
Add to portfolio |
|
|
|
| Price: |
$11.48
| | Metrics |
| OS: |
34.5
|
M
| |
|
|
| Market cap: |
$396
|
M
| |
|
|
|
Net debt:
|
$444
|
M
| |
|
|
|
EV:
|
$840
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 822.5 | 805.8 | 729.0 | 756.3 | 657.5 | 563.6 | 495.9 |
| Revenue growth | 2.1% | 10.5% | -3.6% | 15.0% | 16.7% | 13.6% | |
| Cost of goods sold | 636.0 | 608.7 | 498.4 | 452.4 | 390.9 | 329.8 | 0.0 |
| Gross profit | 186.5 | 197.1 | 230.7 | 303.9 | 266.6 | 233.7 | 495.9 |
| Gross margin | 22.7% | 24.5% | 31.6% | 40.2% | 40.5% | 41.5% | 100.0% |
| General and administrative | 91.1 | 102.0 | 102.8 | 129.9 | 79.3 | 63.0 | 72.6 |
| EBITA | 52.6 | 58.4 | 90.2 | 134.7 | 150.9 | 139.3 | 110.7 |
| EBITA margin | 6.4% | 7.2% | 12.4% | 17.8% | 22.9% | 24.7% | 22.3% |
| Amortization of intangibles | 0.9 | 0.8 | | 1.1 | | | |
| EBIT | 51.7 | 57.6 | 90.2 | 133.6 | 150.9 | 139.3 | 110.7 |
| EBIT margin | 6.3% | 7.2% | 12.4% | 17.7% | 22.9% | 24.7% | 22.3% |
| Pre-tax income | 8.3 | 25.4 | 67.6 | 87.5 | 105.5 | 95.3 | 33.4 |
| Income taxes | -17.8 | 2.9 | 9.5 | -0.8 | 12.4 | 12.9 | -8.2 |
| Tax rate | | 11.4% | 14.0% | | 11.7% | 13.5% | |
| Net income | -21.8 | -31.3 | -16.1 | -7.8 | 18.8 | 16.2 | 41.6 |
| Net margin | -2.6% | -3.9% | -2.2% | -1.0% | 2.9% | 2.9% | 8.4% |
| |
| Diluted EPS | ($0.68) | ($0.98) | ($0.52) | ($0.28) | $0.83 | $0.73 | $1.92 |
| Shares outstanding (diluted) | 32.3 | 32.0 | 31.1 | 28.1 | 22.7 | 22.3 | 21.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|